Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-08-26
Reggio and colleagues identify the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic differentiation in skeletal muscle fibro/adipogenic progenitors. By combining pharmacological screening, mass cytometry, transcriptomics, network modeling, and mouse injury models, the study links impaired WNT5a signaling to pathological muscle fat accumulation and shows how GSK3 inhibition can restrain this process.
-
A23187, Free Acid: From Calcium Flux to Cell Fate
2026-08-26
A mechanistic and translational framework for using A23187, free acid as a calcium ionophore while separating calcium signaling, mitochondrial injury, growth arrest, and cell death in vitro.
-
GnRH Antagonists: Position-3 Design and Activity
2026-08-25
Samant and colleagues examined how replacing position 3 of degarelix with stereochemically distinct 3-(2-methoxy-5-pyridyl)-alanine affects GnRH receptor antagonism and in vivo duration. The study shows that the D-configured analog retained strong in vitro activity, whereas the L-configured counterpart was substantially weaker, yet neither substitution preserved the parent compound’s long-acting profile.
-
Lipidated Nanophotosensitizers Block Tumor EV Metastasis
2026-08-25
The reference study presents a lipidated nanophotosensitizer that traces tumor extracellular vesicles (TEVs) and generates reactive oxygen species in both tumor cells and TEV-associated compartments. This integrated strategy suppresses primary tumor growth while disrupting TEV-mediated communication that supports metastasis, although its translation beyond mouse models requires further pharmacological and mechanistic validation.
-
Bedaquiline at the Energy–Host Interface
2026-08-24
Bedaquiline is more than a diarylquinoline antibiotic: it is a mechanistically distinctive probe of bacterial and mammalian energy metabolism. This thought-leadership article connects ATP synthase inhibition, host-directed tuberculosis biology, cancer stem cell assays, and translational study design.
-
Dorsomorphin 2HCl: AMPK and BMP Pathways
2026-08-24
Dorsomorphin 2HCl is a research-grade AMPK inhibitor and BMP signaling pathway inhibitor for mechanistic studies. Evidence supports its use in metabolic, osteogenic, developmental, and iron homeostasis research, but its dual pathway activity limits AMPK-specific interpretation.
-
ARv7, Enzalutamide, and TNBC Metastasis
2026-08-23
This 2025 study integrates patient pathology, TCGA-BRCA analysis, and mechanistic experiments to examine AR and ARv7 in triple-negative breast cancer. Its findings associate nuclear ARv7 with adverse survival and distant metastasis, while Enzalutamide and EPI-001 reduced metastasis- and epithelial–mesenchymal transition-related signals in MDA-MB-231 cells.
-
EZ Cap™ Mouse IL-12 mRNA (m1Ψ) Workflow
2026-08-22
Build reproducible cytokine-expression assays with a capped, polyadenylated Mouse Interleukin-12 mRNA designed for efficient translation and reduced innate immune activation. This guide connects practical handling and dose-finding with emerging extrahepatic delivery strategies for immunotherapy research mRNA.
-
Busulfan Workflows for Senescence and Germ Cell Models
2026-08-22
Busulfan supports two complementary research use cases: stress-driven senescence induction in WI38 fibroblasts and experimental germ-cell depletion in mice. This guide connects those workflows with dual-recombinase lineage tracing, practical preparation parameters, and troubleshooting strategies that help distinguish tissue injury from genuine cellular regeneration.
-
Lipid Peroxidation (MDA) Assay Kit in Ferroptosis
2026-08-21
The Lipid Peroxidation (MDA) Assay Kit connects quantitative malondialdehyde measurement with ferroptosis research in sepsis-associated acute kidney injury. This guide emphasizes pathway-informed assay design, matrix control, orthogonal validation, and interpretation beyond a single oxidative stress endpoint.
-
CH 223191 in AhR-Driven Ovarian Toxicity
2026-08-20
CH 223191 is an aryl hydrocarbon receptor antagonist for testing whether AhR activation causally links environmental exposures to ovarian follicle dysfunction. This article translates recent mouse follicle findings into a rigorous assay strategy that integrates pathway, hormone, and tissue-level endpoints.
-
Rotigotine Patch: Continuous Dopaminergic Delivery
2026-08-20
The reference review explains how rotigotine’s lipid solubility, dopamine-receptor pharmacology, and sustained skin delivery enabled development of a 24-hour transdermal system for Parkinson’s disease and restless legs syndrome. Its main translational insight is that stable exposure may reduce the limitations of short-acting, pulsatile dopaminergic treatment, although clinical benefits must be interpreted alongside patch-specific tolerability and disease-specific uncertainties.
-
S Tag Peptide: Practical Fusion Tag Guide
2026-08-19
S Tag Peptide supports recombinant protein detection, antibody-based capture, and protein solubility improvement when used as an encoded N- or C-terminal S-peptide fusion tag. The supplied free peptide is water- and DMSO-soluble but should not be treated as an independently active ribonuclease fragment, used in ethanol, or stored long term in solution.
-
Exo1: A Mechanistic Roadmap for Translational Research
2026-08-19
Exo1 provides a mechanism-focused way to interrogate Golgi–ER traffic, ARF1 behavior, and exocytic control. This thought-leadership article connects that cellular tool to emerging tumor extracellular vesicle research while defining the evidence, controls, and translational limits needed for responsible interpretation.
-
Decitabine: Designing Immune-Epigenetic Assays
2026-08-18
Decitabine and 5-Aza-2'-deoxycytidine can do more than erase aberrant DNA methylation. This article presents a phenotype-first framework for separating tumor-cell reprogramming from immune-cell remodeling, grounded in low-dose T-cell evidence and practical assay decisions.